BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp. - Current Ratioverified

BCTXW

Price:

$0.00089999999

Market Cap:

$6.48M

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, currently in Phase 3, dedicated to revolutionizing cancer treatment through its innovative cellular immunotherapies. Its flagship product, Bria-IMT, is currently undergoing a pivotal Phase 3 clinical trial for advanced breast cancer, where it's being evaluated in combination with an immune checkpoint inhibitor. Beyond this lead candidate, the company is also advancing the development of personalized, off-the-shelf treatments designed to combat breast, prostate, and various other forms of cancer. Furthermore, BriaCell maintains a strategic partnership with Incyte Corporation, focused on further evaluating Bria-IMT in combi...[Read more]

Industry

Biotechnology

IPO Date

2012-08-13

Stock Exchange

NASDAQ

Ticker

BCTXW

The Current Ratio as of July 2026 (TTM) for BriaCell Therapeutics Corp. (BCTXW) is 7.07

According to BriaCell Therapeutics Corp.’s latest financial reports and current stock price. The company's current Current Ratio is 7.07. This represents a change of 10.12% compared to the average of 6.42 of the last 4 quarters.

BriaCell Therapeutics Corp. (BCTXW) Historical Current Ratio (quarterly & annually)

How has BCTXW Current Ratio performed in the past?

The mean historical Current Ratio of BriaCell Therapeutics Corp. over the last ten years is 18.99. The current 7.07 Current Ratio has changed 3.62% with respect to the historical average. Over the past ten years (40 quarters), BCTXW's Current Ratio was at its highest in in the January 2017 quarter at 181.81. The Current Ratio was at its lowest in in the January 2021 quarter at 0.06.

Quarterly (TTM)
Annual

Average

18.99

Median

3.43

Minimum

0.07

Maximum

103.81

BriaCell Therapeutics Corp. (BCTXW) Current Ratio by Quarter and Year

Discovering the peaks and valleys of BriaCell Therapeutics Corp. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 157.28%

Maximum Annual Current Ratio = 103.81

Minimum Annual Increase = -96.73%

Minimum Annual Current Ratio = 0.07

Quarterly (TTM)
Annual
YearCurrent RatioChange
20255.01922.88%
20240.49-96.73%
202314.96-66.76%
202245.00-56.65%
2021103.81157.28%
20200.07-55.64%
20190.15-89.39%
20181.40-24.04%
20171.84-89.24%
201617.1561.28%

BriaCell Therapeutics Corp. (BCTXW) Average Current Ratio

How has BCTXW Current Ratio performed in the past?

The current Current Ratio of BriaCell Therapeutics Corp. (BCTXW) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

6.82

5-year avg

33.85

10-year avg

18.99

BriaCell Therapeutics Corp. (BCTXW) Current Ratio vs. Peers

How is BCTXW’s Current Ratio compared to its peers?

BriaCell Therapeutics Corp.’s Current Ratio is greater than Ocean Biomedical, Inc. (0.02), less than SAB Biotherapeutics, Inc. (11.45), greater than Nuwellis, Inc. (1.56), less than Peak Bio, Inc. (21.48), greater than Vincerx Pharma, Inc. (1.21), greater than PetVivo Holdings, Inc. (1.35), less than Lixte Biotechnology Holdings, Inc. (0), greater than Syros Pharmaceuticals, Inc. (3.95), less than Pasithea Therapeutics Corp. (35.40), greater than Celularity Inc. (0.15),

Build a custom stock screener for BriaCell Therapeutics Corp. (BCTXW) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BriaCell Therapeutics Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BriaCell Therapeutics Corp. (BCTXW) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BriaCell Therapeutics Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is BriaCell Therapeutics Corp.'s Current Ratio?

How is the Current Ratio calculated for BriaCell Therapeutics Corp. (BCTXW)?

What is the highest Current Ratio for BriaCell Therapeutics Corp. (BCTXW)?

What is the 3-year average Current Ratio for BriaCell Therapeutics Corp. (BCTXW)?

What is the 5-year average Current Ratio for BriaCell Therapeutics Corp. (BCTXW)?

How does the current Current Ratio for BriaCell Therapeutics Corp. (BCTXW) compare to its historical average?